Certolizumab in the long-term treatment of rheumatoid arthritis
Abdul Khan, David L ScottDepartment of Rheumatology, King’s College London School of Medicine, King’s College, London, UKAbstract: Rheumatoid arthritis is the most common inflammatory arthritis and continues to have major long-term effects on quality of life. Early and in...
Main Authors: | Scott DL, Khan A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-08-01
|
Series: | Open Access Rheumatology : Research and Reviews |
Online Access: | http://www.dovepress.com/certolizumab-in-the-long-term-treatment-of-rheumatoid-arthritis-a8156 |
Similar Items
-
Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
by: M Connock, et al.
Published: (2010-10-01) -
Certolizumab pegol in therapy for rheumatoid arthritis
by: Galina Viktorovna Lukina, et al.
Published: (2012-06-01) -
Anaphylactic reaction by certolizumab in young woman with rheumatoid arthritis
by: Elena Urbieta-Sanz, et al.
Published: (2018-05-01) -
New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
by: Dmitry Evgenyevich Karateev, et al.
Published: (2012-04-01) -
QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
by: Vera Nikolayevna Amirdjanova, et al.
Published: (2012-10-01)